FDA Establishment Registration vs. Device Listing: What Medical Device Companies Must Know

Two Requirements, One Common Mistake

Ask most medical device startup founders whether their company is registered with the FDA, and they will confidently say yes. Ask whether their devices are properly listed, and the conversation gets uncomfortable fast. These are two distinct, legally required obligations under 21 CFR Part 807, and conflating them — or completing one without the other — puts your entire commercial operation at risk.

At ADB Consulting and CRO Inc., we see this gap constantly, particularly among early-stage device companies that are moving quickly from development into commercialization. This post breaks down exactly what each requirement entails, where companies go wrong, and what you need to do to stay on the right side of FDA enforcement.

What Is FDA Establishment Registration?

Establishment registration is the process by which your facility — not your product — is formally identified with the FDA. Under 21 CFR Part 807, Subpart B, any domestic manufacturer, specification developer, single-use device reprocessor, or distributor who repackages or relabels devices must register their establishment with the FDA annually.

Foreign establishments that export devices to the United States are subject to the same requirement under 21 CFR 807.40. Registration is completed through the FDA Unified Registration and Listing System (FURLS), specifically the Device Registration and Listing Module (DRLM). The annual registration period runs from October 1 through December 31, and fees apply to most device establishments. For fiscal year 2025, the standard registration fee is set by FDA and subject to annual adjustment — confirm the current amount directly on FDA.gov before submitting.

What registration does is simple: it tells the FDA who you are and where you operate. It does not authorize you to market any specific product. That is where device listing comes in.

What Is Device Listing?

Device listing is the separate, concurrent obligation to notify the FDA of the specific devices your establishment manufactures or distributes. Per 21 CFR 807.20 and 807.25, listing must be submitted at the time of initial registration and updated within 30 days of any changes — including adding new devices, discontinuing products, or modifying device names.

Each listed device must be assigned the correct FDA Product Code, which maps to the device classification under 21 CFR Parts 862 through 892. Selecting the wrong Product Code is one of the most common technical errors we see — and it can trigger an automatic rejection or, worse, go unnoticed until an inspection reveals the discrepancy.

Device listing is not a clearance or approval. You are not asking the FDA for permission to market your device through the listing process. You are providing mandatory transparency about what products are associated with your registered facility. The actual pathway to market — 510(k), De Novo, PMA, or exempt status — is a separate determination entirely.

Why You Need Both — And Why They Are Not Interchangeable

Registration without listing means you have a facility on record but no devices tied to it. Listing without registration is structurally impossible — FURLS will not permit device listing for an unregistered establishment. But the more nuanced failure mode is submitting both incompletely or inaccurately.

Under Section 510 of the Federal Food, Drug, and Cosmetic Act and the implementing regulations in 21 CFR Part 807, failure to register or list is a prohibited act. It can result in:

• FDA refusal to accept premarket submissions (510(k), PMA) from your establishment
• Import alerts for foreign establishments
• Warning letters and potential injunctive action
• Seizure of devices that are commercially distributed without proper listing

FDA publishes the list of registered establishments and listed devices publicly, and you can verify an FDA registration directly in that database. Hospitals, distributors, and international regulatory bodies routinely search this database during supplier qualification. If your establishment does not appear — or your device is not listed — you may lose commercial contracts long before FDA takes formal enforcement action.

Common Pitfalls We See in Practice

Several patterns appear repeatedly in our regulatory consulting engagements:

• Missing the annual renewal window: Registration must be renewed each year between October 1 and December 31. Missing this window results in lapsed registration status, which can block 510(k) acceptance.
• Incorrect establishment type selection: Manufacturers, contract manufacturers, specification developers, and distributors have different registration obligations. Choosing the wrong type creates compliance gaps.
• Listing exempt devices incorrectly: Class I exempt devices still require listing in most cases under 21 CFR 807.65. Exemption from 510(k) is not the same as exemption from listing.
• Failing to update listings after product changes: New product iterations with different indications or product codes require updated or new listings within 30 days of commercial distribution.
• Overlooking contract manufacturer obligations: If you outsource manufacturing, both your specification developer establishment and your contract manufacturer may have independent registration and listing obligations.

How to Approach This Correctly From Day One

The registration and listing process is procedurally straightforward — but strategically, it requires getting the foundational elements right from the outset. That means correctly classifying your device, selecting the accurate Product Code, determining your establishment type, and understanding whether a premarket pathway is required before distribution begins.

For companies expanding internationally, keep in mind that FDA registration does not satisfy Health Canada Medical Device Establishment License requirements, EU EUDAMED obligations under the MDR, or country-specific requirements in other markets. Each jurisdiction has its own parallel framework.

Building a compliant registration and listing structure early — rather than retrofitting it during a regulatory inspection or M and A due diligence — is always the less expensive path.

Work With a Regulatory Partner Who Gets It Right

At ADB Consulting and CRO Inc., we provide an FDA device registration and listing service that helps medical device startups and growing companies navigate both requirements accurately and efficiently. Whether you are registering for the first time, cleaning up legacy compliance gaps, or preparing for a product launch, our team provides the regulatory expertise to get it done right.

Do not let a preventable administrative error stall your 510(k) submission or block your commercial launch. Book a free discovery call with Andre Butler and the ADB Consulting team today at adbccro.com. Let us build your regulatory foundation the right way.